BACKGROUND AND PURPOSE: The Student Human Papillomavirus Survey (SHPVS) was developed to examine students' perceived benefits or barriers to human papillomavirus (HPV) vaccination. METHODS: Survey development included (a) 2-phase integrative literature reviews; (b) draft of survey items based on the literature; (c) critique of survey items by young adults, nursing and psychology faculty, and health care providers; and (d) pilot testing. The psychometric properties of the SHPVS were evaluated using classical item analysis and exploratory factor analysis (EFA) among a sample of 527 university students' ages 18-24 years. RESULTS: The estimated Cronbach's alpha for the SHPVS is .74. CONCLUSIONS: The SHPVS is a measure of young adults HPV perceived vulnerability, perceived severity, perceived barriers, and perceived benefits of HPV vaccination.
BACKGROUND AND PURPOSE: The Student Human Papillomavirus Survey (SHPVS) was developed to examine students' perceived benefits or barriers to human papillomavirus (HPV) vaccination. METHODS: Survey development included (a) 2-phase integrative literature reviews; (b) draft of survey items based on the literature; (c) critique of survey items by young adults, nursing and psychology faculty, and health care providers; and (d) pilot testing. The psychometric properties of the SHPVS were evaluated using classical item analysis and exploratory factor analysis (EFA) among a sample of 527 university students' ages 18-24 years. RESULTS: The estimated Cronbach's alpha for the SHPVS is .74. CONCLUSIONS: The SHPVS is a measure of young adults HPV perceived vulnerability, perceived severity, perceived barriers, and perceived benefits of HPV vaccination.
Authors: Betty Chou; Lauren S Krill; Bernice B Horton; Christopher E Barat; Cornelia L Trimble Journal: Obstet Gynecol Date: 2011-07 Impact factor: 7.661
Authors: Maria E Fernandez; Sheryl A McCurdy; Sarah R Arvey; Sandra K Tyson; Daisy Morales-Campos; Belinda Flores; Bernardo Useche; Lisa Mitchell-Bennett; Maureen Sanderson Journal: Ethn Health Date: 2009-12 Impact factor: 2.772
Authors: J Paavonen; P Naud; J Salmerón; C M Wheeler; S-N Chow; D Apter; H Kitchener; X Castellsague; J C Teixeira; S R Skinner; J Hedrick; U Jaisamrarn; G Limson; S Garland; A Szarewski; B Romanowski; F Y Aoki; T F Schwarz; W A J Poppe; F X Bosch; D Jenkins; K Hardt; T Zahaf; D Descamps; F Struyf; M Lehtinen; G Dubin Journal: Lancet Date: 2009-07-06 Impact factor: 79.321
Authors: Aaron Esagoff; Samuel A Cohen; Guoxuan Chang; Ozlem Equils; Sarah Van Orman Journal: Hum Vaccin Immunother Date: 2021-03-11 Impact factor: 3.452